Diagnostic efficacy of 18F-rhPSMA7 positron emission tomography for lymph node staging in patients with high-risk primary prostate cancer

MLA

Alexander Wurzer, et al. “Diagnostic Efficacy of 18F-RhPSMA7 Positron Emission Tomography for Lymph Node Staging in Patients with High-Risk Primary Prostate Cancer.” European Urology Supplements, vol. 18, Mar. 2019, p. e215. EBSCOhost, https://doi.org/10.1016/s1569-9056(19)30157-5.

APA

Alexander Wurzer, Tobias Maurer, M. Kroenke, H.-J. Wester, Wolfgang Weber, Bernhard Haller, Kristina Schwamborn, L. Jooß, L. Ulrich, Matthias Eiber, & Thomas Horn. (2019). Diagnostic efficacy of 18F-rhPSMA7 positron emission tomography for lymph node staging in patients with high-risk primary prostate cancer. European Urology Supplements, 18, e215. https://doi.org/10.1016/s1569-9056(19)30157-5

Chicago

Alexander Wurzer, Tobias Maurer, M. Kroenke, H.-J. Wester, Wolfgang Weber, Bernhard Haller, Kristina Schwamborn, et al. 2019. “Diagnostic Efficacy of 18F-RhPSMA7 Positron Emission Tomography for Lymph Node Staging in Patients with High-Risk Primary Prostate Cancer.” European Urology Supplements 18 (March): e215. doi:10.1016/s1569-9056(19)30157-5.